MedTrace Logo

Blood Virome After Haploidentical Hematopoietic Stem Cell Transplantation, a Pilot Study

NCT05622032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2025-04-02

No results posted yet for this study

Summary

The goal of this observational study is to assess the risk of viral infections in patients receiving hematopoietic stem cell transplantation (HSCT) from a haploidentical donor compared to those who receive HSCT from a HLA-matched donor. The main question it aims to answer is: to describe which viruses are replicating in the blood of the above two patient groups on the day of transplantation and at 1, 3 and 6 months after transplantation. Blood samples taken as part of routine care on the day of transplantation and at 1, 3 and 6 months post-transplantation visits are analyzed and the types and amount of viruses detected in the two groups of patients are described.

Conditions

  • Haploidentical Hematopoietic Stem Cell Transplantation

Sponsors & Collaborators

  • Laurent Kaiser

    lead OTHER

Principal Investigators

  • Laurent Kaiser, Pr, MD · University Hospital, Geneva

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-20
Primary Completion
2025-03-25
Completion
2025-03-25

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05622032 on ClinicalTrials.gov